Tim earned his Bachelor's degrees in Neuroscience and Cellular, Molecular, and Developmental Biology in 2015 from the University of Colorado in Boulder, where he studied the role of neuroinflammation in drug addiction. Post-graduate research at CU Boulder explored the development of neuropathic pain and the mechanisms involved in effective therapeutic interventions, such as preemptive exercise. Tim then spent time as a lab manager at MD Anderson conducting research on chemotherapy-induced peripheral neuropathy. Next, as a research scientist in R&D at a medical devices company, Tim helped develop and modify diagnostic ELISAs. He also conducted literature and market research for business development efforts. In August 2019, Tim joined the Pharmaceutical Sciences PhD program and is now investigating the roles of oxidative stress and redox signaling cascades in epileptogenesis in the Patel Lab. This thesis work aims to identify novel therapeutic drug targets that are involved in aberrant oxidative signaling in epilepsy. In his spare time, Tim enjoys hiking 14ers, backpacking, and skiing.